Ultrasound-responsive lipid microbubbles for drug delivery: A review of preparation techniques to optimise formulation size, stability and drug loading

Int J Pharm. 2020 Jul 30:585:119559. doi: 10.1016/j.ijpharm.2020.119559. Epub 2020 Jun 20.

Abstract

Lipid-shelled microbubbles have received extensive interest to enhance ultrasound-responsive drug delivery outcomes due to their high biocompatibility. While therapeutic effectiveness of microbubbles is well established, there remain limitations in sample homogeneity, stability profile and drug loading properties which restrict these formulations from seeing widespread use in the clinical setting. In this review, we evaluate and discuss the most encouraging leads in lipid microbubble design and optimisation. We examine current applications in drug delivery for the systems and subsequently detail shell compositions and preparation strategies that improve monodispersity while retaining ultrasound responsiveness. We review how excipients and storage techniques help maximise stability and introduce different characterisation and drug loading techniques and evaluate their impact on formulation performance. The review concludes with current quality control measures in place to ensure lipid microbubbles can be reproducibly used in drug delivery.

Keywords: Drug loading; Formulation strategies; Phospholipid microbubbles; Size standardisation; Stability; Ultrasound contrast agents.

Publication types

  • Review

MeSH terms

  • Drug Delivery Systems / methods*
  • Drug Storage / methods
  • Drug Storage / standards
  • Excipients / chemistry
  • Humans
  • Microbubbles*
  • Particle Size
  • Phospholipids / chemistry
  • Quality Control
  • Surface-Active Agents / chemistry
  • Technology, Pharmaceutical / methods*
  • Ultrasonography

Substances

  • Excipients
  • Phospholipids
  • Surface-Active Agents